Allianz Achieves Record Profits in First Half 2024
August 8, 2024
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240807213448/en/
Oliver Bäte, Chief Executive Officer of Allianz SE (Photo: Allianz SE)
2Q 2024:
- Total business volume advances 7.6 percent to 42.6 billion euros
- Operating profit reaches 3.9 billion euros driven by good results in all segments
- Shareholders’ core net income stable at 2.5 billion euros
6M 2024:
- Total business volume rises by 6.4 percent to 91.0 billion euros
- Operating profit increases by 5.3 percent to 7.9 billion euros driven by all segments
- Shareholders’ core net income advances 7.7 percent to 5.0 billion euros
- Strong Solvency II capitalization ratio of 206 percent1
Outlook:
- 2024 operating profit target affirmed at 14.8 billion euros, plus or minus 1 billion euros2
Other:
- Share buy-back of 1 billion euros executed by the end of July 2024
- Decision to expand the total volume of the share buy-backs in the financial year 2024 to a total of 1.5 billion euros
- Allianz has therefore resolved to repurchase additional shares in a volume of up to 500 million euros
1 | Based on quarterly dividend accrual; additional accrual to reflect FY dividend would impact solvency II capitalization ratio by -6%-p as of June 30, 2024. | |
2 | As always, natural catastrophes and adverse developments in the capital markets, as well as factors stated in our cautionary note regarding forward-looking statements may severely affect the operating profit and/or net income of our operations and the results of the Allianz Group. |
”Allianz delivered strong results in the first six months of the year and we are confident in our ability to achieve our full-year ambitions.
Our performance demonstrates the core strengths and resilience of our company, particularly as our results were achieved amid significant natural catastrophe activity in the second quarter – and notably in our home market. The way that Allianz responded to our customers affected by the floods in Germany reflected the best possible blend of compassion, speed, and expertise. Teams enabled by digital claims processing tools visited nearly all affected properties within two weeks of the event, which reassured our customers and limited damages.
These excellent property and casualty outcomes were complemented by strong delivery in our life/health, and asset management segments, demonstrating how we translate our customer-centric strategy into resilient earnings growth.”
- Oliver Bäte, Chief Executive Officer of Allianz SE
FINANCIAL HIGHLIGHTS |
Total business volume
2Q 2024: Total business volume rose by 7.6 percent to 42.6 billion euros. This increase was driven by strong momentum across all business segments.
Adjusted for foreign currency translation and consolidation effects, internal growth was 8.8 percent. The Property-Casualty segment was the main driver, but all business segments contributed positively.
6M 2024: Total business volume increased by 6.4 percent to 91.0 billion euros. All business segments contributed to this growth.
Adjusted for foreign currency translation and consolidation effects, internal growth was 7.5 percent.
Earnings
2Q 2024: Operating profit was very good at 3.9 (2Q 2023: 3.8) billion euros. All segments contributed to this result. The Property-Casualty business showed a strong underlying performance which largely offset the impact of elevated natural catastrophes.
Shareholders’ core net income was stable at 2.5 (2.5) billion euros.
Net income attributable to shareholders rose to 2.5 (2.3) billion euros driven by operating profit growth, and higher non-operating result.
6M 2024: Operating profit was strong at 7.9 (6M 2023: 7.5) billion euros, up by 5.3 percent, driven by all business segments. The Life/Health segment achieved widespread growth across most regions. In Asset Management, higher AuM-driven revenues were the main drivers while the Property-Casualty business benefited from strong growth and underlying performance.
Shareholders’ core net income advances 7.7 percent to 5.0 billion euros.
Net income attributable to shareholders increased by 14.2 percent to 5.0 (4.4) billion euros driven by operating profit growth, and higher non-operating result.
Core earnings per share (EPS)3 was 12.57 (6M 2023: 11.40) euros.
The annualized core return on equity (RoE)3 was 17.5 percent (full year 2023: 16.1 percent).
The share buy-back program of up to 1 billion euros, announced on February 22, 2024, has been executed by the end of July 2024. The Board of Management has decided to expand the total volume of the share buy-backs in the financial year 2024 to a total of 1.5 billion euros and has therefore resolved to repurchase additional shares in a volume of up to 500 million euros.
3 | Core EPS and core RoE calculation based on shareholders‘ core net income. |
Solvency II capitalization ratio
The Solvency II capitalization ratio was 206 percent4 at the end of second quarter 2024 compared with 203 percent at the end of the first quarter 2024.
4 | Based on quarterly dividend accrual; additional accrual to reflect FY dividend would impact solvency II capitalization ratio by -6%-p as of June 30, 2024. |
SEGMENTAL HIGHLIGHTS |
“Allianz’s results for the second quarter and the consistency of our performance confirm our sustained momentum and the resilience of our business model.
- In our Property-Casualty segment, we achieved a very good operating profit. This shows our ability to deliver strong results even as we were impacted by severe natural catastrophes in particular in Germany. Our continuous focus on productivity is as well supporting our performance.
- We have reached an excellent operating profit in our Life/Health operations. Our strong new business generation and a healthy new business margin speak for the attractiveness of our products.
- In Asset Management, continued net inflows of 14.1 billion euros in the second quarter bring our net inflows for the first half to 48.4 billion euros. Our third-party assets under management exceeded 1.8 trillion euros for the first time since 1Q 2022. This is a good basis for future profit growth.
“We look with confidence to the second half of 2024 and affirm our outlook for an operating profit of 14.8 billion euros plus or minus 1 billion euros for the full year.”
- Claire-Marie Coste-Lepoutre, Chief Financial Officer of Allianz SE
Property-Casualty insurance: Strong operating profit
2Q 2024: Total business volume increased by 9.4 percent to 19.3 (17.6) billion euros. Adjusted for foreign currency translation and consolidation effects, internal growth was 10.5 percent. Very good growth of 12 percent in Retail, SME & Fleet was the main driver while Commercial lines advanced by 9 percent.
Operating profit was 1.9 (2.0) billion euros – a resilient performance in light of elevated natural catastrophe and weather losses.
The combined ratio amounted to 93.5 percent (92.2 percent). The loss ratio was 69.2 percent (67.4 percent) as significantly higher claims from natural catastrophes were partly offset by better run-off. The underlying profitability has improved in line with expectations. The expense ratio also developed favourably by 0.5 percentage points to 24.2 percent.
6M 2024: Total business volume increased by 7.3 percent to 44.8 (41.7) billion euros. Adjusted for foreign currency translation and consolidation effects, internal growth was 8.1 percent. In Retail, SME & Fleet growth amounted to 9 percent while Commercial lines contributed by 5 percent.
Operating profit rose by 3.3 percent to an excellent level of 4.0 (3.9) billion euros.
The combined ratio came in at 92.7 percent (92.0 percent). The loss ratio was 68.3 percent (67.2 percent) as higher claims from natural catastrophes were partly offset by better run-off. The underlying profitability has improved in line with expectations. The expense ratio improved by 0.4 percentage points to 24.4 percent.
Life/Health insurance: Very good growth
2Q 2024: PVNBP, the present value of new business premiums, increased to 18.8 (17.7) billion euros, driven by higher volume in most entities. Adjusted for one large contract in the prior year period, PVNBP is up by 14.7 percent.
Operating profit advanced to 1.4 (1.2) billion euros, driven by all regions.
Contractual Service Margin (CSM) rose from 53.2 billion euros in the first quarter to 53.6 billion euros, driven by good normalized CSM growth of 1.3 percent slightly offset by non-economic impacts.
The new business margin (NBM) was strong at 5.8 percent (6.2 percent). The value of new business (VNB) remained at a very good level of 1.1 (1.1) billion euros.
6M 2024: PVNBP rose to 41.1 (36.2) billion euros, supported by strong sales in capital efficient products.
Operating profit increased to 2.7 (2.5) billion euros due to positive developments in nearly all regions.
Contractual service margin (CSM) rose to 53.6 billion euros from 52.6 billion euros at the end of 2023, driven by a normalized CSM growth of 3.1 percent.
The new business margin was strong at 5.7 percent (5.8 percent). The value of new business rose to 2.4 (2.1) billion euros, primarily driven by volume growth in most entities.
Asset Management: Good operating profit and strong net inflows
2Q 2024: Operating revenues increased to 2.0 billion euros, up 4.4 percent adjusted for foreign currency translation effects. Higher AuM-driven revenues more than offset lower performance fees.
Operating profit rose to 742 (703) million euros, up 5.6 percent. Adjusted for foreign currency translation effects, operating profit increased by 4.8 percent. The cost-income ratio (CIR) was stable at 62.4 percent (62.5 percent).
Third-party assets under management increased to 1.803 trillion euros as of June 30, 2024, up by 19 billion euros from the end of the first quarter 2024, reaching the highest level since the first quarter 2022. The main driver were net inflows of 14.1 billion euros with further positive contribution from favorable foreign currency translation effects.
Total assets under management rose to 2.309 trillion euros at the end of the second quarter of 2024, up 12 billion euros from the end of the first quarter 2024 in line with the results for the third-party assets under management.
6M 2024: Operating revenues increased to 4.0 billion euros, up 5.1 percent adjusted for foreign currency translation effects. The increase was largely driven by higher AuM-driven revenues.
Operating profit rose to 1.5 (1.4) billion euros, up 6.3 percent. Adjusted for foreign currency translation effects, operating profit increased by 6.5 percent. The cost-income ratio (CIR) improved to 61.8 percent (62.3 percent).
Third-party assets under managementincreased by 91 billion euros from the end of 2023 to 1.803 trillion euros as of June 30, 2024. Strong net inflows of 48.4 billion euros were the main contributor.
2Q & 6M 2024 RESULTS TABLE |
Allianz Group - key figures 2nd quarter and first half year 2024 | ||||||||||||||||||
2Q
|
2Q
| Delta |
6M
|
6M
| Delta | |||||||||||||
Total business volume | € bn | 42.6 | 39.6 | 7.6% | 91.0 | 85.6 | 6.4% | |||||||||||
- Property-Casualty | € bn | 19.3 | 17.6 | 9.4% | 44.8 | 41.7 | 7.3% | |||||||||||
- Life/Health | € bn | 21.5 | 20.3 | 6.2% | 42.7 | 40.4 | 5.5% | |||||||||||
- Asset Management | € bn | 2.0 | 1.9 | 5.2% | 4.0 | 3.8 | 4.9% | |||||||||||
- Consolidation | € bn | -0.2 | -0.2 | -4.5% | -0.3 | -0.3 | 2.4% | |||||||||||
Operating profit / loss | € mn | 3,926 | 3,783 | 3.8% | 7,911 | 7,513 | 5.3% | |||||||||||
- Property-Casualty | € mn | 1,915 | 1,983 | -3.4% | 3,981 | 3,855 | 3.3% | |||||||||||
- Life/Health | € mn | 1,379 | 1,202 | 14.7% | 2,705 | 2,521 | 7.3% | |||||||||||
- Asset Management | € mn | 742 | 703 | 5.6% | 1,516 | 1,426 | 6.3% | |||||||||||
- Corporate and Other | € mn | -112 | -111 | 1.1% | -291 | -287 | 1.4% | |||||||||||
- Consolidation | € mn | 2 | 6 | -66.6% | 0 | -2 | -92.4% | |||||||||||
Net income | € mn | 2,661 | 2,486 | 7.0% | 5,293 | 4,647 | 13.9% | |||||||||||
- attributable to non-controlling interests | € mn | 149 | 150 | -0.9% | 305 | 278 | 9.5% | |||||||||||
- attributable to shareholders | € mn | 2,513 | 2,337 | 7.5% | 4,988 | 4,369 | 14.2% | |||||||||||
Shareholders’ core net income1 | € mn | 2,536 | 2,517 | 0.8% | 5,049 | 4,690 | 7.7% | |||||||||||
Core earnings per share2 | € | 6.15 | 5.97 | 3.0% | 12.57 | 11.40 | 10.2% | |||||||||||
Additional KPIs | ||||||||||||||||||
- Group | Core return on equity3 | % | – | – | – | 17.5% | 16.1% | 1.4% | -p | |||||||||
- Property-Casualty | Combined ratio | % | 93.5% | 92.2% | 1.3% | -p | 92.7% | 92.0% | 0.7% | -p | ||||||||
- Life/Health | New business margin | % | 5.8% | 6.2% | -0.4% | -p | 5.7% | 5.8% | -0.1% | -p | ||||||||
- Asset Management | Cost-income ratio | % | 62.4% | 62.5% | -0.1% | -p | 61.8% | 62.3% | -0.5% | -p | ||||||||
06/30/2024 | 12/31/2023 | Delta | ||||||||||||||||
Shareholders' equity4 | € bn | 55.5 | 58.2 | -4.7% | ||||||||||||||
Contractual service margin (net) | € bn | 33.7 | 32.7 | 2.9% | ||||||||||||||
Solvency II capitalization ratio5 | % | 206% | 206% | 0% | -p | |||||||||||||
Third-party assets under management | € bn | 1,803 | 1,712 | 5.3% | ||||||||||||||
Please note: The figures are presented in millions of Euros, unless otherwise stated. Due to rounding, numbers presented may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures. | ||||||||||||||||||
1_ | Presents the portion of shareholders’ net income before non-operating market movements and before amortization of intangible assets from business combinations (including any related income tax effects). | |||||||||||||||||
2_ | Calculated by dividing the respective period’s shareholders' core net income, adjusted for net financial charges related to undated subordinated bonds classified as shareholders' equity, by the weighted average number of shares outstanding (basic core EPS). | |||||||||||||||||
3_ | Represents the annualized ratio of shareholders’ core net income to the average shareholders’ equity at the beginning and at the end of the period. Shareholders’ core net income is adjusted for net financial charges related to undated subordinated bonds classified as shareholders’ equity. From the average shareholders’ equity, undated subordinated bonds classified as shareholders’ equity, unrealized gains and losses from insurance contracts and other unrealized gains and losses are excluded. Annualized figures are not a forecast for full year numbers. For 6M 2023, the core return on equity for the respective full year is shown. Due to an adjustment of prior periods comparative figures for the balance sheet, the core RoE changed by +0.1%-p compared to the published figure as of 31 December 2023. | |||||||||||||||||
4_ | Excluding non-controlling interests. In 1Q 2024 Allianz reclassified certain minority interests between equity and liabilities. Prior periods comparative figures for the balance sheet have been adjusted with a minor impact on shareholders’ equity only (reduced by EUR 0.2bn as of 31 December 2023). | |||||||||||||||||
5_ | Risk capital figures are group diversified at 99.5% confidence level. Solvency II capitalization ratio is based on quarterly dividend accrual; additional accrual to reflect FY dividend would impact solvency II capitalization ratio by -6%-p as of 30 June 2024. | |||||||||||||||||
RELATED LINKS |
Media Conference
August 8, 2024, 11 AM CEST: YouTubeEnglish line
Analyst Conference
August 8, 2024, 2:30 PM CEST: YouTubeEnglish line
Results
The results and related documents can be found in the download center.
UPCOMING EVENTS |
Financial Results 3Q 2024
November 13, 2024
Capital Markets Day
December 10, 2024
More information can be found in the financial calendar.
About Allianz
The Allianz Group is one of the world's leading insurers and asset managers with around 125 million* private and corporate customers in nearly 70 countries. Allianz customers benefit from a broad range of personal and corporate insurance services, ranging from property, life and health insurance to assistance services to credit insurance and global business insurance. Allianz is one of the world’s largest investors, managing around 741 billion euros** on behalf of its insurance customers. Furthermore, our asset managers PIMCO and Allianz Global Investors manage about 1.8 trillion euros** of third-party assets. Thanks to our systematic integration of ecological and social criteria in our business processes and investment decisions, we are among the leaders in the insurance industry in the Dow Jones Sustainability Index. In 2023, over 157,000 employees achieved total business volume of 161.7 billion euros and an operating profit of 14.7 billion euros for the group.
* Including non-consolidated entities with Allianz customers. |
**As of June 30, 2024. |
These assessments are, as always, subject to the disclaimer provided below.
Cautionary note regarding forward-looking statements
This document includes forward-looking statements, such as prospects or expectations, that are based on management's current views and assumptions and subject to known and unknown risks and uncertainties. Actual results, performance figures, or events may differ significantly from those expressed or implied in such forward-looking statements.
Deviations may arise due to changes in factors including, but not limited to, the following: (i) the general economic and competitive situation in the Allianz’s core business and core markets, (ii) the performance of financial markets (in particular market volatility, liquidity, and credit events), (iii) adverse publicity, regulatory actions or litigation with respect to the Allianz Group, other well-known companies and the financial services industry generally, (iv) the frequency and severity of insured loss events, including those resulting from natural catastrophes, and the development of loss expenses, (v) mortality and morbidity levels and trends, (vi) persistency levels, (vii) the extent of credit defaults, (viii) interest rate levels, (ix) currency exchange rates, most notably the EUR/USD exchange rate, (x) changes in laws and regulations, including tax regulations, (xi) the impact of acquisitions including and related integration issues and reorganization measures, and (xii) the general competitive conditions that, in each individual case, apply at a local, regional, national, and/or global level. Many of these changes can be exacerbated by terrorist activities.
No duty to update
Allianz assumes no obligation to update any information or forward-looking statement contained herein, save for any information we are required to disclose by law.
Other
The figures regarding the net assets, financial position and results of operations have been prepared in conformity with International Financial Reporting Standards. This Quarterly Earnings Release is not an Interim Financial Report within the meaning of International Accounting Standard (IAS) 34. This is a translation of the German Quarterly Earnings Release of the Allianz Group. In case of any divergences, the German original is binding.
Privacy Note
Allianz SE is committed to protecting your personal data. Find out more in our privacy statement.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240807213448/en/
Contacts
Frank Stoffel Tel. +49 89 3800 18124 email: frank.stoffel@allianz.com
Fabrizio Tolotti Tel. +49 89 3800 14819 email: fabrizio.tolotti@allianz.com
Johanna Oltmann Tel. +49 89 3800 13346 email: johanna.oltmann@allianz.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Announces US FDA Approval of ALYFTREK ™ , a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis20.12.2024 21:46:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily next-in-class triple combination cystic fibrosis transmembrane conductance regulator (CFTR) modulator for the treatment of cystic fibrosis (CF) in people 6 years and older who have at least one F508del mutation or another mutation in the CFTR gene that is responsive to ALYFTREK. See below for Important Safety Information, including a Boxed Warning. “ALYFTREK is our fifth CFTR modulator to secure FDA approval and represents another significant milestone in our journey to serially innovate and to improve the lives of people living with cystic fibrosis,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex. “Our north star for more than 20 years has been to address the underlying cause of cystic fibrosis, treat more people with this disease, and bring more people to normal le
Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non- F508del TRIKAFTA-Responsive Variants20.12.2024 21:35:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of people with cystic fibrosis (CF) ages 2 and older who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a mutation that is responsive to TRIKAFTA based on clinical and/or in vitro data. In addition, safety information on liver injury and liver failure has been updated from warnings and precautions to a boxed warning. With this approval, 94 additional non-F508delCFTR mutations have been added to the TRIKAFTA label, and approximately 300 additional people with CF in the U.S. are now eligible for a medicine to treat the underlying cause of their disease for the first time. “Since its first approval in 2019, TRIKAFTA has had a transformative impact on tens of thousands of people living with cystic fibrosis,” sai
HSBC Continental Europe Enters Into a Memorandum of Understanding Regarding Potential Sale of HSBC Assurances Vie (France) to Matmut Société d’Assurance Mutuelle20.12.2024 20:32:00 CET | Press Release
Regulatory News: HSBC Continental Europe has signed a Memorandum of Understanding (‘MOU‘) regarding the potential sale of its French life insurance business, HSBC Assurances Vie (France), to Matmut Société d’Assurance Mutuelle (‘Matmut’) (the “Potential Transaction”). HSBC Assurances Vie (France) provides a wide range of life insurance solutions and services, with over 20 billion euros of outstanding assets, net income1 of 77 million euros and a Solvency II ratio of 287% in 2023. As part of the Potential Transaction, HSBC Continental Europe and Matmut would enter into a long-term arrangement for HSBC Global Asset Management (France) to continue to partner with HSBC Assurances Vie (France). HSBC Assurances Vie (France) will continue its existing distribution arrangements. The Potential Transaction would provide customers and employees of HSBC Insurance Life (France) with the opportunity to join one of the leading French mutual insurance groups, which is in full development, and forms pa
SBC Medical Group Co., Ltd. Sells Two Subsidiaries20.12.2024 13:00:00 CET | Press Release
On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas. The subsidiaries being sold operate in the following industries: Kijimadaira: Ski resort operations SNA: Flight training operations The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To e
Aarhus University: New Global Study Sheds Light on the Learning Crisis: Three Years After COVID-1920.12.2024 13:00:00 CET | Press Release
TIMSS 2023 has revealed an alarming global learning crisis exacerbated by the COVID-19 pandemic. Compared to the long term trend in progress in mathematics and science achievement has not only stalled but reversed when taking school closures into account, with the most vulnerable students facing the steepest losses. Key Findings Global Achievement Decline: A 0.11 standard deviation drop in student performance reflects the pandemic's lasting impact. Disproportionate Impact: Low performers, girls, and language minorities faced losses up to twice the average (0.22 standard deviations), deepening existing inequities. Regional Variations: Countries with prolonged school closures and limited remote learning resources experienced the steepest declines. Why This Matters School closures disrupted the education of over one billion children worldwide, with disadvantaged students suffering the most. “The widening gender gap in STEM fields is particularly troubling,” said Christian Kjeldsen, incomi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom